BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 28769798)

  • 21. For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis.
    Caplin S; Cerottini JP; Bosman FT; Constanda MT; Givel JC
    Cancer; 1998 Aug; 83(4):666-72. PubMed ID: 9708929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative genomic hybridization analysis of primary colorectal carcinomas and their synchronous metastases.
    Al-Mulla F; Keith WN; Pickford IR; Going JJ; Birnie GD
    Genes Chromosomes Cancer; 1999 Apr; 24(4):306-14. PubMed ID: 10092128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutations of the APC gene in human sporadic colorectal cancers.
    De Filippo C; Luceri C; Caderni G; Pacini M; Messerini L; Biggeri A; Mini E; Tonelli F; Cianchi F; Dolara P
    Scand J Gastroenterol; 2002 Sep; 37(9):1048-53. PubMed ID: 12374230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decision analysis in the surgical treatment of colorectal cancer due to a mismatch repair gene defect.
    de Vos tot Nederveen Cappel WH; Buskens E; van Duijvendijk P; Cats A; Menko FH; Griffioen G; Slors JF; Nagengast FM; Kleibeuker JH; Vasen HF
    Gut; 2003 Dec; 52(12):1752-5. PubMed ID: 14633956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative serum levels of CEA and CA 19-9 and their prognostic significance in colorectal carcinoma.
    Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Pahl H; Fateh-Moghadam A
    Anticancer Res; 1997; 17(4B):2935-8. PubMed ID: 9329568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lifestyle factors and p53 mutation patterns in colorectal cancer patients in the EPIC-Norfolk study.
    Park JY; Mitrou PN; Keen J; Dahm CC; Gay LJ; Luben RN; McTaggart A; Khaw KT; Ball RY; Arends MJ; Rodwell SA
    Mutagenesis; 2010 Jul; 25(4):351-8. PubMed ID: 20228093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improvement of 10-year survival by Japanese radical lymph node dissection in patients with Dukes' B and C colorectal cancer: a 17-year retrospective study.
    Mukai M; Ito I; Mukoyama S; Tajima T; Saito Y; Nakasaki H; Sato S; Makuuchi H
    Oncol Rep; 2003; 10(4):927-34. PubMed ID: 12792747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical evaluation of thymidylate synthase (TS) and p16INK4a in advanced colorectal cancer: implication of TS expression in 5-FU-based adjuvant chemotherapy.
    Kamoshida S; Matsuoka H; Ishikawa T; Maeda K; Shimomura R; Inada K; Tsutsumi Y
    Jpn J Clin Oncol; 2004 Oct; 34(10):594-601. PubMed ID: 15591457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of the Serum Level of Carcinoembryonic Antigen and Prolactin with Different Stages of Colorectal Carcinoma According to Dukes' Staging.
    Rahman MR; Sheikh SH; Lima IJ; Islam MR; Faisal M; Islam MS; Faruk MO; Jalal MT
    Mymensingh Med J; 2016 Jan; 25(1):61-5. PubMed ID: 26931251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p53 and Ki-ras as prognostic factors for Dukes' stage B colorectal cancer.
    Bouzourene H; Gervaz P; Cerottini JP; Benhattar J; Chaubert P; Saraga E; Pampallona S; Bosman FT; Givel JC
    Eur J Cancer; 2000 May; 36(8):1008-15. PubMed ID: 10885605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival in patients with large-bowel cancer. A population-based investigation from the Melbourne Colorectal Cancer Study.
    Kune GA; Kune S; Field B; White R; Brough W; Schellenberger R; Watson LF
    Dis Colon Rectum; 1990 Nov; 33(11):938-46. PubMed ID: 2226081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of adjuvant chemo- or immunotherapy on the prognosis of colorectal cancer operated for cure.
    Wunderlich M; Schiessel R; Rainer H; Rauhs R; Kovats E; Schemper M; Dittrich C; Micksche M; Sedlacek HH
    Br J Surg; 1985 Sep; 72 Suppl():S107-10. PubMed ID: 3899250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Performance validation of an amplicon-based targeted next-generation sequencing assay and mutation profiling of 648 Chinese colorectal cancer patients.
    Wang Y; Liu H; Hou Y; Zhou X; Liang L; Zhang Z; Shi H; Xu S; Hu P; Zheng Z; Liu R; Tang T; Ye F; Liang Z; Bu H
    Virchows Arch; 2018 Jun; 472(6):959-968. PubMed ID: 29705968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different distribution of Dukes' stage between proximal and distal colorectal cancer.
    Ikeda Y; Akagi K; Kinoshita J; Abe T; Miyazaki M; Mori M; Sugimachi K
    Hepatogastroenterology; 2002; 49(48):1535-7. PubMed ID: 12397728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterogeneity of mutant versus wild-type Ki-ras in primary and metastatic colorectal carcinomas, and association of codon-12 valine with early mortality.
    Al-Mulla F; Going JJ; Sowden ET; Winter A; Pickford IR; Birnie GD
    J Pathol; 1998 Jun; 185(2):130-8. PubMed ID: 9713338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel multiplexed immunoassay identifies CEA, IL-8 and prolactin as prospective markers for Dukes' stages A-D colorectal cancers.
    Mahboob S; Ahn SB; Cheruku HR; Cantor D; Rennel E; Fredriksson S; Edfeldt G; Breen EJ; Khan A; Mohamedali A; Muktadir MG; Ranganathan S; Tan SH; Nice E; Baker MS
    Clin Proteomics; 2015; 12(1):10. PubMed ID: 25987887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Usefulness of CTCs in tumor drainage vein blood as a biomarker for prognosis in colorectal cancer patients with Dukes' stage B and C].
    Shimada R; Iinuma H; Tamura J; Horiuchi A; Nozawa K; Ishihara S; Matsuda K; Watanabe T; Hashiguchi Y
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):1763-5. PubMed ID: 23267879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Next-generation sequencing for genetic testing of familial colorectal cancer syndromes.
    Simbolo M; Mafficini A; Agostini M; Pedrazzani C; Bedin C; Urso ED; Nitti D; Turri G; Scardoni M; Fassan M; Scarpa A
    Hered Cancer Clin Pract; 2015; 13(1):18. PubMed ID: 26300997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modifying Effects of Glucose and Insulin/Insulin-Like Growth Factors on Colon Cancer Cells.
    Berk Ş; Janssen JAMJL; van Koetsveld PM; Dogan F; Değerli N; Özcan S; Kelestimur F; Hofland LJ
    Front Oncol; 2021; 11():645732. PubMed ID: 34290976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dukes' staging is poorly understood by doctors managing colorectal cancer.
    Mainprize KS; Mortensen NJ; Warren BF
    Ann R Coll Surg Engl; 2002 Jan; 84(1):23-5. PubMed ID: 11892729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.